CA2716509A1 - Procede de traitement de la photosensibilite et de la phototoxicite - Google Patents

Procede de traitement de la photosensibilite et de la phototoxicite Download PDF

Info

Publication number
CA2716509A1
CA2716509A1 CA2716509A CA2716509A CA2716509A1 CA 2716509 A1 CA2716509 A1 CA 2716509A1 CA 2716509 A CA2716509 A CA 2716509A CA 2716509 A CA2716509 A CA 2716509A CA 2716509 A1 CA2716509 A1 CA 2716509A1
Authority
CA
Canada
Prior art keywords
alpha
msh
analogue
photosensitivity
phototoxicity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2716509A
Other languages
English (en)
Inventor
Philippe Wolgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clinuvel Pharmaceuticals Ltd
Original Assignee
Clinuvel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008900858A external-priority patent/AU2008900858A0/en
Application filed by Clinuvel Pharmaceuticals Ltd filed Critical Clinuvel Pharmaceuticals Ltd
Publication of CA2716509A1 publication Critical patent/CA2716509A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A61K38/34—Melanocyte stimulating hormone [MSH], e.g. alpha- or beta-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2716509A 2008-02-22 2009-02-20 Procede de traitement de la photosensibilite et de la phototoxicite Abandoned CA2716509A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2008900858 2008-02-22
AU2008900858A AU2008900858A0 (en) 2008-02-22 Method for treatment of photosensitivity and phototoxicity following the use of photosensitizers in photodynamic therapy
AU2008900857 2008-02-22
AU2008900857A AU2008900857A0 (en) 2008-02-22 Method for treatment of photosensitivity and phototoxicity followng the use of photosensitizing agent
PCT/EP2009/052093 WO2009103816A1 (fr) 2008-02-22 2009-02-20 Procédé de traitement de la photosensibilité et de la phototoxicité

Publications (1)

Publication Number Publication Date
CA2716509A1 true CA2716509A1 (fr) 2009-08-27

Family

ID=40546019

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2716509A Abandoned CA2716509A1 (fr) 2008-02-22 2009-02-20 Procede de traitement de la photosensibilite et de la phototoxicite

Country Status (4)

Country Link
EP (1) EP2259794A1 (fr)
AU (1) AU2009216681A1 (fr)
CA (1) CA2716509A1 (fr)
WO (1) WO2009103816A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067503A1 (fr) * 2013-11-07 2015-05-14 Clinuvel Ag Analogues de l'alpha-msh destinés à être utilisés dans le traitement du psoriasis
WO2016195476A1 (fr) * 2015-05-29 2016-12-08 Erasmus University Medical Center Rotterdam Traitement d'arythmies cardiaques
BR112022025115A2 (pt) 2020-06-10 2023-02-07 Mitsubishi Tanabe Pharma Corp Agente profilático ou terapêutico para fotodermatose

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL102645A (en) * 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
US6147195A (en) * 1993-07-26 2000-11-14 Yeda Research And Development Co., Ltd. Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
WO2005048967A1 (fr) * 2003-11-24 2005-06-02 Clinuvel Pharmaceuticals Limited Procede permettant d'induire la melanogenese chez des sujets humains au moyen d'alleles variants du mc1r
EP2368562B1 (fr) * 2004-10-08 2015-06-17 Clinuvel Pharmaceuticals Limited Compositions et procédés pour induire la mélanogenèse chez un sujet
PL2865422T3 (pl) * 2006-08-31 2018-01-31 Clinuvel Pharmaceuticals Ltd Pochodne alfa-MSH do leczenia fotodermatoz
WO2008033395A2 (fr) * 2006-09-14 2008-03-20 Biorexis Pharmaceutical Corporation Protéines de fusion mélanocortine et transferrine

Also Published As

Publication number Publication date
EP2259794A1 (fr) 2010-12-15
AU2009216681A1 (en) 2009-08-27
WO2009103816A1 (fr) 2009-08-27

Similar Documents

Publication Publication Date Title
CA2662163C (fr) Methode de traitement de photodermatoses
EP1789076B1 (fr) Procédés d'induction de mélanogenese chez un sujet
US11622994B2 (en) Therapy for vitiligo
CA2716509A1 (fr) Procede de traitement de la photosensibilite et de la phototoxicite
AU2007291943B2 (en) Method for reducing incidence or rate of development of skin cancers and related conditions
AU2009228664B2 (en) Therapy for vitiligo

Legal Events

Date Code Title Description
FZDE Dead